The results of the present study demonstrate for the first time that the CD45 expression is altered in inflammation in a leucocyte subtype-specific manner, as evidenced in vitro in endotoxemia and in vivo in COVID-19 infection. This evidence concerns the gene PTPRC and serum lipopolysaccharide activity.